Please use this identifier to cite or link to this item:
https://www.arca.fiocruz.br/handle/icict/55663
Type
ArticleCopyright
Open access
Collections
- INI - Artigos de Periódicos [3460]
Metadata
Show full item record
REFRACTORY SPOROTRICHOSIS LESION: AN EFFECTIVE AND PIONEERING APPROACH IN A PATIENT LIVING WITH HUMAN IMMUNODEFICIENCY VIRUS/ACQUIRED IMMUNODEFICIENCY SYNDROME
Author
Affilliation
Hospital Federal de Bonsucesso. Departamento de Dermatologia. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil.
Hospital Federal de Bonsucesso. Departamento de Dermatologia. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil.
Hospital Federal de Bonsucesso. Departamento de Dermatologia. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil.
Hospital Federal de Bonsucesso. Departamento de Dermatologia. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil.
Hospital Federal de Bonsucesso. Departamento de Dermatologia. Rio de Janeiro, RJ, Brasil.
Abstract
Sporotrichosis is a subcutaneous mycosis caused
by fungi of the genus Sporothrix.
Since 1998, in the
metropolitan region of Rio de Janeiro, there has been
an increase in the number of human cases, in a
zoonotic transmission pattern, from domestic and
stray cats, involving Sporothrix brasiliensis as the
causative species.
The primary treatment for this infection includes
oral itraconazole, potassium iodide, terbinafine, and
intravenous amphotericin B. Refractory cases and
the cases in which the patients have contraindications to pharmacological treatment may benefit from
adjuvant methods such as cryosurgery, thermotherapy, and electrosurgery.
Here, we report a case of lymphocutaneous
sporotrichosis refractory to itraconazole treatment
that achieved clinical cure after electrosurgery with
curettage.
Share